{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:29:28Z","timestamp":1780050568377,"version":"3.53.1"},"reference-count":12,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p>A 50\u2010year\u2010old male developed headache, impaired balance, visual defects and severe deafness. Ten months later he presented with markedly reduced power and tremor of his right arm. Waldenstr\u00f6m's macroglobulinaemia (WM) with accompanying polyneuropathy was diagnosed. The patient received chemotherapy, which resulted in a partial improvement of the arm tremor. Subsequently, he was treated with rituximab (4\u2003\u00d7 375\u2003mg\/m<jats:sup>2<\/jats:sup>), leading to complete resolution of the tremor and the paresis of his arm. Additionally, his headache and imbalance disappeared. Fifteen\u2003months after rituximab therapy he remained free of any neurological symptoms. This is the first report showing that WM\u2010associated polyneuropathy can be treated effectively with a combination of chemotherapy and the anti\u2010CD20 monoclonal antibody rituximab.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.02086.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:25:35Z","timestamp":1047363935000},"page":"838-841","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The polyneuropathy associated with Waldenstr\u00f6m's macroglobulinaemia can be treated effectively with chemotherapy and the anti\u2010CD20 monoclonal antibody rituximab"],"prefix":"10.1111","volume":"109","author":[{"given":"R.","family":"Weide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Heymanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"K\u00f6ppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_4_2_1","first-page":"85","article-title":"Experiences in the diagnosis and treatment of polyneuropathies in patients with malignant monoclonal gammopathy","volume":"42","author":"Baumann I.","year":"1990","journal-title":"Psychiatrics Neurological Medicine Psychological (Leipzig)"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30276-0"},{"key":"e_1_2_4_4_1","article-title":"rituximab therapy in previously treated Waldenstr\u00f6m's macroglobulinemia","volume":"92","author":"Byrd J.C.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_4_5_1","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.V83.6.1452.1452","article-title":"Waldenstr\u00f6m's macroglobulinemia","volume":"83","author":"Dimopoulos M.A.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.6.1671"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1987.tb07904.x"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520360073015"},{"key":"e_1_2_4_9_1","article-title":"IDEC\u2010C2B8 anti\u2010CD20 antibody: final report on a phase III pivotal trial in patients with relapsed low grade or follicular lymphoma","volume":"88","author":"McLaughlin P.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199003083221002"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.49.2.181"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(93)90297-C"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909145966"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02086.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02086.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.02086.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T09:59:30Z","timestamp":1698573570000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.02086.x"}},"subtitle":["SHORT REPORT"],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1365-2141.2000.02086.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02086.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}